CA2113795A1 - Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes - Google Patents

Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes

Info

Publication number
CA2113795A1
CA2113795A1 CA002113795A CA2113795A CA2113795A1 CA 2113795 A1 CA2113795 A1 CA 2113795A1 CA 002113795 A CA002113795 A CA 002113795A CA 2113795 A CA2113795 A CA 2113795A CA 2113795 A1 CA2113795 A1 CA 2113795A1
Authority
CA
Canada
Prior art keywords
slps
particles
dispersion
lipid
anyone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002113795A
Other languages
English (en)
Inventor
Kirsten Westesen
Britta Siekmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Kabi Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia AB filed Critical Kabi Pharmacia AB
Priority to CA002113795A priority Critical patent/CA2113795A1/fr
Publication of CA2113795A1 publication Critical patent/CA2113795A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Water Supply & Treatment (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
CA002113795A 1994-01-19 1994-01-19 Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes Abandoned CA2113795A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002113795A CA2113795A1 (fr) 1994-01-19 1994-01-19 Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002113795A CA2113795A1 (fr) 1994-01-19 1994-01-19 Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes

Publications (1)

Publication Number Publication Date
CA2113795A1 true CA2113795A1 (fr) 1995-07-20

Family

ID=4152767

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002113795A Abandoned CA2113795A1 (fr) 1994-01-19 1994-01-19 Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes

Country Status (1)

Country Link
CA (1) CA2113795A1 (fr)

Similar Documents

Publication Publication Date Title
CA2091152C (fr) Particules lipidiques solides, particules d'agents bioactifs, et methode de preparation et d'utilisation
US5885486A (en) Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5785976A (en) Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
EP0711151B1 (fr) Particules ayant des proprietes physiochimiques modifiees, leur preparation et leurs utilisations
Shirodkar et al. Solid lipid nanoparticles and nanostructured lipid carriers: emerging lipid based drug delivery systems
US7008646B2 (en) Cubic liquid crystalline compositions and methods for their preparation
Mehnert et al. Solid lipid nanoparticles: production, characterization and applications
Attama et al. Lipid nanoparticulate drug delivery systems: a revolution in dosage form design and development
AU714978B2 (en) Pharmaceutical nanosuspensions for medicament administration as systems of increased saturation solubility and rate of solution
CN100551365C (zh) 制备紫杉醇亚微米颗粒的方法
KR20020011985A (ko) 액상 및 고체상 지질 혼합물에 기초한 지질입자들 및 그의제조방법
AU4917900A (en) Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
Nastruzzi Lipospheres in drug targets and delivery: approaches, methods, and applications
Pragati et al. Solid lipid nanoparticles: a promising drug delivery technology
Im-Emsap et al. Disperse systems
CA2113795A1 (fr) Particules lipidiques solides, particules d'agents bioactifs et methodes de fabrication et d'utilisation correspondantes
Kuntsche et al. Solid lipid nanoparticles (SLN) for drug delivery
Khurana et al. Nanostructured lipid carriers and their application in drug delivery
Sharma et al. Solid lipid nanoparticles: A promising nanotechnology
Bagade et al. Solid lipid nanoparticles: a critical appraisal
CN102227210A (zh) 亲脂性物质溶液，特别是药物溶液

Legal Events

Date Code Title Description
FZDE Discontinued